Literature DB >> 34108804

Choosing the Most Appropriate Treatment Option for Pelvic Venous Disease: Stenting versus Embolization.

Mari E Tanaka1, Oleksandra Kutsenko2, Gloria Salazar3.   

Abstract

Pelvic venous disease (PeVD) in women encompasses a wide variety of entities all resulting in pelvic pain and varices. Successful treatment with percutaneous interventions is dependent on identifying underlying factors contributing to the disease and addressing them with either embolization of incompetent veins or stenting for venous stenoses. There are a multitude of embolization methods with marked practice heterogeneity. Moreover, with the ongoing development of dedicated venous stents in the treatment of chronic venous disease, there are more opportunities to consider this modality for the treatment of PeVD, as many patients present with combined vein reflux and central venous stenosis. The necessity to address both and the order of interventions in these patients is still to be elucidated. Here, we describe when to choose stenting or embolization for PeVD, their limitations, and our practice and identify further areas of research in this field. Thieme. All rights reserved.

Entities:  

Keywords:  embolization; interventional radiology; pelvic venous disease; stenting

Year:  2021        PMID: 34108804      PMCID: PMC8175116          DOI: 10.1055/s-0041-1727104

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.780


  39 in total

Review 1.  Effectiveness of Embolization or Sclerotherapy of Pelvic Veins for Reducing Chronic Pelvic Pain: A Systematic Review.

Authors:  Jane P Daniels; Rita Champaneria; Laila Shah; Janesh K Gupta; Judy Birch; Jonathan G Moss
Journal:  J Vasc Interv Radiol       Date:  2016-07-07       Impact factor: 3.464

2.  Unusual case of left iliac vein compression secondary to May-Thurner syndrome and crossed fused renal ectopia.

Authors:  Mohamed A Elsharawy; Khaled M Moghazy; Hind S Alsaif; Mosad M Al-Asiri
Journal:  Saudi Med J       Date:  2008-04       Impact factor: 1.484

3.  Identification and Treatment of Restenosis in Failing Venous Stents: The Role of Intravascular Ultrasound.

Authors:  P E Thorpe
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2013-12-12

4.  Iliac vein stenosis is an underdiagnosed cause of pelvic venous insufficiency.

Authors:  Ratnam K N Santoshi; Sanjiv Lakhanpal; Vinay Satwah; Gaurav Lakhanpal; Michael Malone; Peter J Pappas
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2017-12-29

Review 5.  Endovascular Treatment of an Anatomically Complex Iliac Lesion and a Review of Variant Iliac Venous Anatomy.

Authors:  Daniel M DePietro; Tim Carlon; Scott O Trerotola; Deepak Sudheendra
Journal:  J Vasc Interv Radiol       Date:  2019-12-26       Impact factor: 3.464

6.  Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions - short-term safety, patency, and clinical outcomes.

Authors:  Michael Lichtenberg; Frank Breuckmann; Wilhelm Friedrich Stahlhoff; Peter Neglén; de Graaf Rick
Journal:  Vasa       Date:  2018-09-03       Impact factor: 1.961

7.  A randomized controlled trial of medroxyprogesterone acetate and psychotherapy for the treatment of pelvic congestion.

Authors:  C M Farquhar; V Rogers; S Franks; S Pearce; J Wadsworth; R W Beard
Journal:  Br J Obstet Gynaecol       Date:  1989-10

8.  Anomalous veins of the retroperitoneum: clinical considerations.

Authors:  H S Sürücü; K M Erbil; C Tastan; N Yener
Journal:  Surg Radiol Anat       Date:  2001       Impact factor: 1.246

9.  Embolization of ovarian vein for pelvic congestion syndrome with ethylene vinyl alcohol copolymer (Onyx®).

Authors:  C Marcelin; J Izaaryene; M Castelli; P A Barral; A Jacquier; V Vidal; J M Bartoli
Journal:  Diagn Interv Imaging       Date:  2017-06-22       Impact factor: 4.026

10.  Pelvic venous incompetence: reflux patterns and treatment results.

Authors:  G Asciutto; K C Asciutto; A Mumme; B Geier
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-07-01       Impact factor: 7.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.